tiprankstipranks
Trending News
More News >

Proteomics International Laboratories Ltd Announces ASX Quotation of New Securities

Story Highlights
  • Proteomics International Laboratories Ltd is in the biotechnology industry, focusing on diagnostic tests.
  • The company is quoting over 10 million securities on ASX to boost market presence.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Proteomics International Laboratories Ltd Announces ASX Quotation of New Securities

Confident Investing Starts Here:

Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has shared an announcement.

Proteomics International Laboratories Ltd has announced the application for quotation of 10,810,811 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions and is expected to enhance the company’s market presence and provide additional capital for its operations, potentially impacting its industry positioning positively.

More about Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd operates in the biotechnology industry, specializing in the development of diagnostic tests based on proteomics, which is the study of proteins and their functions. The company focuses on providing innovative solutions for disease detection and management, aiming to enhance healthcare outcomes.

YTD Price Performance: -51.25%

Average Trading Volume: 132,410

Technical Sentiment Signal: Buy

Current Market Cap: A$51.09M

See more insights into PIQ stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App